UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

The effect of organisational factors and processes of care on between centre achievement of audit measures for calcium, phosphate and PTH in UK haemodialysis.
UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 15th Annual Report Figure 8.1. Age and gender of PD patients submitted to audit.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
UK Renal Registry 18th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
Fig 7.1 Median URR achieved in each renal unit
South West Home Therapies Conference
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Peer Review Oct 2017 Haemodialysis Graphs.
CHAPTER 7 Nutritional Status on Dialysis
CHAPTER 3 Death and Survival on Dialysis
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
UK Renal Registry 13th Annual Report
CHAPTER 10 Hepatitis on Dialysis
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 12th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 14th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
Presentation transcript:

UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1– 1.7 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.2. Funnel plot of percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.3. Percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.4. Funnel plot of percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.5. Longitudinal change in percentage of patients with phosphate below, within and above the 2010 RA standard by dialysis modality 2003–2013

UK Renal Registry 17th Annual Report Figure 8.6. Percentage of haemodialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.7. Funnel plot of percentage of haemodialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.8. Percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure 8.9. Funnel plot of percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Longitudinal change in percentage of patients with adjusted calcium 2.5 mmol/L by dialysis modality 2003–2013

UK Renal Registry 17th Annual Report Figure Percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Funnel plot of percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Funnel plot of percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Longitudinal change in percentage of patients with PTH within range (16–72 pmol/L) by dialysis modality 2003–2013

UK Renal Registry 17th Annual Report Figure Percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

UK Renal Registry 17th Annual Report Figure Percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

UK Renal Registry 17th Annual Report Figure Funnel plot for percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

UK Renal Registry 17th Annual Report Figure Funnel plot for percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

UK Renal Registry 17th Annual Report Figure Percentage of haemodialysis patients with serum bicarbonate within range (18–24 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Funnel plot for percentage of haemodialysis patients within the range for bicarbonate (18–24 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Percentage of peritoneal dialysis patients with serum bicarbonate within range (22–30 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Funnel plot for percentage of peritoneal dialysis patients within the range for bicarbonate (22–30 mmol/L) by centre in 2013

UK Renal Registry 17th Annual Report Figure Longitudinal change in percentage of patients within the range for bicarbonate (18–24 mmol/L for HD and 22–30 mmol/L for PD) by dialysis modality 2003–2013

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.